Philippe Menu
Chief Medical Officer at SOPHiA GENETICS SA (SOPH)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $503K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Oct 7SEC | SOPHSOPHiA GENETICS SA | Sell Plan | 7,394200,993 held (−4%) | $8.13 | $60K | -8.8% |
| Sep 16SEC | SOPHSOPHiA GENETICS SA | Sell Plan | 5,000208,387 held (−2%) | $7.88 | $39K | -6.0% |
| Aug 26SEC | SOPHSOPHiA GENETICS SA | Sell Plan | 5,000213,387 held (−2%) | $8.68 | $43K | -14.6% |
| Aug 14SEC | SOPHSOPHiA GENETICS SA | Sell Plan | 5,000218,387 held (−2%) | $7.52 | $38K | -1.5% |
| Jul 28SEC | SOPHSOPHiA GENETICS SA | Sell Plan | 5,000223,387 held (−2%) | $5.66 | $28K | +30.9% |
| Jul 14SEC | SOPHSOPHiA GENETICS SA | Sell Plan | 5,000228,387 held (−2%) | $5.70 | $28K | +30.0% |
| Jul 7SEC | SOPHSOPHiA GENETICS SA | Sell Plan | 7,393233,387 held (−3%) | $5.16 | $38K | +43.6% |
| Jun 26SEC | SOPHSOPHiA GENETICS SA | Sell Plan | 5,000240,780 held (−2%) | $5.50 | $28K | +34.7% |
| Jun 15SEC | SOPHSOPHiA GENETICS SA | Sell Plan | 5,000245,780 held (−2%) | $4.95 | $25K | +49.7% |
| Jun 1SEC | SOPHSOPHiA GENETICS SA | Sell Plan | 5,000250,780 held (−2%) | $4.95 | $25K | +49.7% |
| May 20SEC | SOPHSOPHiA GENETICS SA | Sell Plan | 608255,780 held (−0%) | $4.61 | $3K | +60.7% |
| May 13SEC | SOPHSOPHiA GENETICS SA | Sell Plan | 5,000256,388 held (−2%) | $4.67 | $23K | +58.7% |
| Apr 28SEC | SOPHSOPHiA GENETICS SA | Sell Plan | 5,000261,388 held (−2%) | $4.82 | $24K | +53.7% |
| Apr 21SEC | SOPHSOPHiA GENETICS SA | Sell Plan | 608266,388 held (−0%) | $5.20 | $3K | +42.5% |
| Apr 16SEC | SOPHSOPHiA GENETICS SA | Sell Plan | 1,600266,996 held (−1%) | $4.96 | $8K | +49.4% |
| Apr 14SEC | SOPHSOPHiA GENETICS SA | Sell Plan | 3,725272,996 held (−1%) | $4.68 | $17K | +58.3% |
| Apr 14SEC | SOPHSOPHiA GENETICS SA | Sell Plan | 1,000271,996 held (−0%) | $4.76 | $5K | +55.7% |
| Apr 14SEC | SOPHSOPHiA GENETICS SA | Sell Plan | 3,400268,596 held (−1%) | $4.76 | $16K | +55.7% |
| Apr 10SEC | SOPHSOPHiA GENETICS SA | Sell Plan | 2,800278,652 held (−1%) | $4.84 | $14K | +53.1% |
| Apr 10SEC | SOPHSOPHiA GENETICS SA | Sell Plan | 1,931276,721 held (−1%) | $4.74 | $9K | +56.3% |
| Apr 8SEC | SOPHSOPHiA GENETICS SA | Sell Plan | 2,700283,852 held (−1%) | $4.85 | $13K | +52.8% |
| Apr 8SEC | SOPHSOPHiA GENETICS SA | Sell Plan | 2,400281,452 held (−1%) | $4.87 | $12K | +52.2% |
| Mar 20SEC | SOPHSOPHiA GENETICS SA | Sell Plan | 608173,616 held (−0%) | $4.79 | $3K | +54.7% |
- Sell
Chief Medical Officer Philippe Menu sold $60K of SOPH at $8.13 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Philippe Menu sold $39K of SOPH at $7.88 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Philippe Menu sold $43K of SOPH at $8.68 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Philippe Menu sold $38K of SOPH at $7.52 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Philippe Menu sold $28K of SOPH at $5.66 — pre-scheduled 10b5-1 plan sale.
- Sell
Chief Medical Officer Philippe Menu sold $28K of SOPH at $5.70 — pre-scheduled 10b5-1 plan sale.